GSK funding has been allocated to new research programmes combining expertise and using cutting edge AI technology to ...

Moderna has announced a $140 million investment to enhance its Massachusetts manufacturing capacity, a move that supports ...

Just a few weeks after the company announced licensing agreements with Empirico and Syndivia, GSK announced a strategic ...

GSK plc and the Fleming Initiative have announced six major new research programs to find new ways to slow the progress of ...

One of the projects launched by the Fleming Initiative will develop AI models to speed discovery of new antibiotics for ...

The UK turns to artificial intelligence (AI) to reverse the rising numbers of infections that shrug off antibiotics.

(Alliance News) - GSK PLC and Fleming Initiative on Wednesday unveiled six major research programmes aimed at tackling antimicrobial resistance, committing GBP45 million to projects that will harness ...

According to GSK, the programme of 'Grand Challenge' research projects will make use of AI and other cutting-edge ...

GSK and the Fleming Initiative have announced six new research programmes to combat antimicrobial resistance (AMR), backed by ...

Supercomputers will take on superbugs in a new venture between pharmaceutical company GSK and UK scientists to use artificial ...

In recent years, superbugs have become a global threat to healthcare. Given the fatal nature, the UK scientists have come ...